NMR methods in fragment based drug discovery

被引:0
|
作者
Lim, Jongsoo [1 ]
机构
[1] Innovat Med Res Labs, Mol Pharmacol Team, 21 Geumhwa Ro 105 Beon Gil, Yongin 446905, Gyeonggi Do, South Korea
来源
关键词
FBDD; HTS; NMR; Fragment library quality control;
D O I
10.6564/JKMRS.2015.19.3.132
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear magnetic resonance (NMR) spectroscopy, owing to its ability to provide atomic level information on molecular structure, dynamics and interaction, has become one of the most powerful methods in early drug discovery where hit finding and hit-to-lead generation are mainly pursued. In recent years, drug discovery programs originating from the fragment-based drug discovery (FBDD) strategies have been widely incorporated into academia and industry in which a wide variety of NMR methods become an indispensable arsenal to elucidate the binding of small molecules onto bimolecular targets. In this review, I briefly describe FBDD and introduce NMR methods mainly used in FBDD campaigns of my company. In addition, quality control of fragment library and practical NMR methods in industrial aspect are discussed shortly.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [31] Tethering: Fragment-based drug discovery
    Erlanson, DA
    Wells, JA
    Braisted, AC
    ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 : 199 - 223
  • [32] Case histories in fragment based drug discovery
    Johnson, Christopher N.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [33] The rise of fragment-based drug discovery
    Murray C.W.
    Rees D.C.
    Nature Chemistry, 2009, 1 (3) : 187 - 192
  • [34] Computational techniques in fragment based drug discovery
    Villar, Hugo O.
    Hansen, Mark R.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (15) : 1509 - 1513
  • [35] Counting on Fragment Based Drug Design Approach for Drug Discovery
    Kashyap, Aanchal
    Singh, Pankaj Kumar
    Silakari, Om
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (27) : 2284 - 2293
  • [36] What makes a good fragment in fragment-based drug discovery?
    Konteatis, Zenon
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (07) : 723 - 726
  • [37] Fragment-Based Drug Discovery for Trypanosoma brucei Glycosylphosphatidylinositol-Specific Phospholipase C through Biochemical and WaterLOGSY-NMR Methods
    Ibrahim, Mohammed Auwal
    Yamasaki, Tomoko
    Furukawa, Koji
    Yamasaki, Kazuhiko
    JOURNAL OF BIOCHEMISTRY, 2022, 171 (06): : 619 - 629
  • [38] Fragment-Based Lead Discovery Strategies in Antimicrobial Drug Discovery
    Konaklieva, Monika I.
    Plotkin, Balbina J.
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [39] Fragment based drug discovery of allosteric FAK inhibitors
    Cossio, Osvaldo
    Campos-Olivas, Ramon
    Santiveri Martin-Vares, Clara
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [40] Fragment-based drug discovery: Less is more
    Heightman, Tom D.
    CANCER RESEARCH, 2014, 74 (19)